Detalles de la búsqueda
1.
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.
Eur J Haematol
; 111(1): 63-71, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36964939
2.
Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort study.
Haematologica
; 107(5): 1111-1118, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34233446
3.
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies.
Eur J Nucl Med Mol Imaging
; 49(3): 953-962, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480603
4.
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience.
Ann Hematol
; 101(8): 1769-1776, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35731278
5.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Ann Hematol
; 101(4): 755-762, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083525
6.
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cells.
Eur J Haematol
; 108(1): 52-60, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34564876
7.
Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy-A Single Center Prospective Cohort Study.
Transplant Cell Ther
; 28(5): 278.e1-278.e4, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35182795
8.
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.
Transplant Cell Ther
; 27(9): 788-794, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34214738
Resultados
1 -
8
de 8
1
Próxima >
>>